An evaluation of point and interval estimates in population pharmacokinetics using NONMEM analysis
- PMID: 2023111
- DOI: 10.1007/BF01062194
An evaluation of point and interval estimates in population pharmacokinetics using NONMEM analysis
Abstract
In a simulation study of the estimation of population pharmacokinetic parameters, including fixed and random effects, the estimates and confidence intervals produced by NONMEM were evaluated. Data were simulated according to a monoexponential model with a wide range of design and statistical parameters, under both steady state (SS) and non-SS conditions. Within the range of values for population parameters commonly encountered in research and clinical settings, NONMEM produced parameter estimates for CL, V, sigma CL, and sigma epsilon which exhibit relatively small biases. As the range of variability increases, these biases became larger and more variable. An important exception was bias in the estimate for sigma V which was large even when the underlying variability was small. NONMEM standard error estimates are appropriate as estimates of standard deviation when the underlying variability is small. Except in the case of CL, standard error estimates tend to deteriorate as underlying variability increases. An examination of confidence interval coverage indicates that caution should be exercised when the usual 95% confidence intervals are used for hypothesis testing. Finally, simulation-based corrections of point and interval estimates are possible but corrections must be performed on a case-by-case basis.
Comment in
-
Response to "An evaluation of point and interval estimates in population pharmacokinetics using NONMEM analysis" by White et al.J Pharmacokinet Biopharm. 1992 Aug;20(4):389-95. doi: 10.1007/BF01062464. J Pharmacokinet Biopharm. 1992. PMID: 1479560 No abstract available.
Similar articles
-
Evaluation of hypothesis testing for comparing two populations using NONMEM analysis.J Pharmacokinet Biopharm. 1992 Jun;20(3):295-313. doi: 10.1007/BF01062529. J Pharmacokinet Biopharm. 1992. PMID: 1522482
-
Estimating inestimable standard errors in population pharmacokinetic studies: the bootstrap with Winsorization.Eur J Drug Metab Pharmacokinet. 2002 Jul-Sep;27(3):213-24. doi: 10.1007/BF03190460. Eur J Drug Metab Pharmacokinet. 2002. PMID: 12365204
-
Parametric and nonparametric population methods: their comparative performance in analysing a clinical dataset and two Monte Carlo simulation studies.Clin Pharmacokinet. 2006;45(4):365-83. doi: 10.2165/00003088-200645040-00003. Clin Pharmacokinet. 2006. PMID: 16584284
-
Inter-study variability in population pharmacokinetic meta-analysis: when and how to estimate it?J Pharm Sci. 2000 Feb;89(2):155-67. doi: 10.1002/(SICI)1520-6017(200002)89:2<155::AID-JPS3>3.0.CO;2-2. J Pharm Sci. 2000. PMID: 10688745 Review.
-
Prior information for population pharmacokinetic and pharmacokinetic/pharmacodynamic analysis: overview and guidance with a focus on the NONMEM PRIOR subroutine.J Pharmacokinet Pharmacodyn. 2020 Oct;47(5):431-446. doi: 10.1007/s10928-020-09695-z. Epub 2020 Jun 13. J Pharmacokinet Pharmacodyn. 2020. PMID: 32535847 Free PMC article. Review.
Cited by
-
Pharmacodynamic parameter estimation: population size versus number of samples.AAPS J. 2005 Oct 5;7(2):46. doi: 10.1208/aapsj070246. AAPS J. 2005. PMID: 16353905 Free PMC article. Review.
-
Evaluation of the nonparametric estimation method in NONMEM VI: application to real data.J Pharmacokinet Pharmacodyn. 2009 Aug;36(4):297-315. doi: 10.1007/s10928-009-9122-z. Epub 2009 Jul 2. J Pharmacokinet Pharmacodyn. 2009. PMID: 19572188
-
Population pharmacodynamic parameter estimation from sparse sampling: effect of sigmoidicity on parameter estimates.AAPS J. 2009 Sep;11(3):535-40. doi: 10.1208/s12248-009-9131-2. Epub 2009 Jul 24. AAPS J. 2009. PMID: 19629711 Free PMC article.
-
Statistical considerations in pharmacokinetic study design.Clin Pharmacokinet. 1993 May;24(5):380-7. doi: 10.2165/00003088-199324050-00003. Clin Pharmacokinet. 1993. PMID: 8504622 Review.
-
Analysis of animal pharmacokinetic data: performance of the one point per animal design.J Pharmacokinet Biopharm. 1995 Dec;23(6):551-66. doi: 10.1007/BF02353461. J Pharmacokinet Biopharm. 1995. PMID: 8733946
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Research Materials